Cargando…
Kininase 1 As a Preclinical Therapeutic Target for Kinin B(1) Receptor in Insulin Resistance
Kinin B1 receptor (B1R) contributes to insulin resistance, an early event in type 2 diabetes, through the upregulation and activation of the inducible form of nitric oxide synthase (iNOS), pro-inflammatory cytokines and the oxidative stress. This study addresses the hypothesis that inhibition of kin...
Autores principales: | Haddad, Youssef, Couture, Réjean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539221/ https://www.ncbi.nlm.nih.gov/pubmed/28824433 http://dx.doi.org/10.3389/fphar.2017.00509 |
Ejemplares similares
-
Localization and Interaction between Kinin B1 Receptor and NADPH Oxidase in the Vascular System of Diabetic Rats
por: Haddad, Youssef, et al.
Publicado: (2017) -
Kinins and Their Receptors as Potential Therapeutic Targets in Retinal Pathologies
por: Othman, Rahmeh, et al.
Publicado: (2021) -
Kallikrein/K1, Kinins, and ACE/Kininase II in Homeostasis and in Disease Insight From Human and Experimental Genetic Studies, Therapeutic Implication
por: Alhenc-Gelas, Francois, et al.
Publicado: (2019) -
Kinin B(1) Receptor Enhances the Oxidative Stress in a Rat Model of Insulin Resistance: Outcome in Hypertension, Allodynia and Metabolic Complications
por: Dias, Jenny Pena, et al.
Publicado: (2010) -
Reciprocal Regulatory Interaction between TRPV1 and Kinin B1 Receptor in a Rat Neuropathic Pain Model
por: Cernit, Veronica, et al.
Publicado: (2020)